News from eli lilly and company A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 27, 2015, 14:30 ET
Eli Lilly and Company logo.

Lilly to Participate in Morgan Stanley Global Healthcare Conference

 Eli Lilly and Company (NYSE: LLY) will attend the Morgan Stanley Global Healthcare Conference on Thursday, September 17, 2015. Sue Mahony,...

Aug 27, 2015, 10:30 ET
Eli Lilly and Company logo.

U.S. FDA approves Synjardy® (empagliflozin/metformin hydrochloride) tablets for adults with type 2 diabetes

The U.S. Food and Drug Administration (FDA) has approved Synjardy® (empagliflozin and metformin hydrochloride) tablets, from Boehringer...

Aug 25, 2015, 17:09 ET
Eli Lilly and Company logo.

U.S. District Court Rules in Lilly's Favor on Alimta Vitamin Regimen Patent

Eli Lilly and Company (NYSE: LLY) today announced that the U.S. District Court for the Southern District of Indiana has ruled in the company's...

Aug 25, 2015, 11:30 ET
Lilly, AACE Mark 10th Anniversary of Hurricane Katrina with Reminder of "My Diabetes Emergency Plan" Checklist

Lilly, AACE Mark 10th Anniversary of Hurricane Katrina with Reminder of "My Diabetes Emergency Plan" Checklist

For Sherry Martin, M.D., starting her new job at Eli Lilly and Company (NYSE: LLY) in August 2005 was stressful enough. She was in the process of...

Aug 20, 2015, 07:30 ET
Eli Lilly and Company logo.

Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced positive top-line results from EMPA-REG OUTCOME®. This is a...

Aug 18, 2015, 10:00 ET
Humalog(R) 200 units/mL KwikPen(R)

Lilly's Humalog® 200 units/mL KwikPen® Now Available in U.S. Pharmacies

 Humalog® 200 units/mL KwikPen® (insulin lispro 200 units/mL; U-200), the first and only concentrated mealtime insulin analog in the...

Aug 04, 2015, 17:06 ET
Eli Lilly and Company logo

Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study

 Eli Lilly and Company (NYSE:LLY) today notified the University of California, San Diego (UCSD) of its intent to end its contract with the...

Jul 27, 2015, 08:00 ET
Eli Lilly and Company logo.

Lilly Provides Update on Evacetrapib Phase 3 Trial

Eli Lilly and Company (NYSE: LLY) has accepted the recommendation of the ACCELERATE study data monitoring committee to continue the Phase 3 trial...

Jul 23, 2015, 12:04 ET
NASCAR driver Ryan Reed

Lilly Diabetes and NASCAR XFINITY Series Driver Ryan Reed Want You to Think About Your Diabetes Pit Crew

 To emphasize the importance of a support system in diabetes management, Lilly Diabetes and NASCAR XFINITY Series driver Ryan Reed will kick...

Jul 23, 2015, 06:32 ET
Eli Lilly and Company logo.

Eli Lilly and Company Announces Expansion of San Diego Biotechnology Center

Eli Lilly and Company (NYSE: LLY) today revealed plans to expand the Lilly Biotechnology Center located in San Diego, Calif. The expansion will...

Jul 23, 2015, 06:25 ET
Eli Lilly and Company logo.

Lilly Reports Second-Quarter 2015 Results, Revises 2015 Financial Guidance

Eli Lilly and Company (NYSE: LLY) today announced financial results for the second quarter of 2015.   $ in millions, except...

Jul 22, 2015, 12:00 ET
Eli Lilly and Company logo.

New Study Shows Florbetapir F 18 Injection Scans Led to Change in Diagnosis and Management of Patients Being Evaluated for Cognitive Decline

Eli Lilly and Company (NYSE: LLY) and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, today announced new data showing that...

Jul 22, 2015, 07:00 ET
Eli Lilly and Company logo.

Data Using New Delayed-Start Methodology Suggested Benefit of Early Treatment with Solanezumab in Patients with Mild Alzheimer's Disease

Eli Lilly and Company (NYSE: LLY) today announced results suggesting the treatment effect of solanezumab was preserved within a pre-specified...

Jul 14, 2015, 15:00 ET
Eli Lilly and Company logo.

Lilly Diabetes Launches Android Version of Glucagon Mobile Application for Those Who Support People with Diabetes

News Highlights - Now for Android: Lilly Diabetes' Glucagon Mobile App to support #diabetes caregivers - Leverage the power of...

Jul 09, 2015, 13:55 ET
Eli Lilly and Company logo.

Lilly Statement on FDA Advisory Committee Review of Necitumumab

 The U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) met today to discuss the data supporting Eli Lilly and...

Jul 01, 2015, 13:30 ET
Eli Lilly and Company logo.

Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement

Eli Lilly and Company (NYSE: LLY) will announce its financial results for the second quarter of 2015 on Thursday, July 23, 2015. Lilly will also...

Jun 29, 2015, 08:00 ET
Eli Lilly and Company logo.

Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma

 Eli Lilly and Company (NYSE: LLY) and Immunocore Limited today announced that they have entered into an immunotherapy-based clinical trial...

Jun 25, 2015, 09:00 ET
Diabetes Scholars Foundation.

Diabetes Scholars Foundation Announces 2015 Scholarship Recipients

Attending college is a critical milestone in the lives of many young people. But balancing college life and a full course load while keeping a...

Jun 25, 2015, 06:00 ET
Eli Lilly and Company logo.

UK Court Rules in Favor of Lilly in Alimta Vitamin Regimen Patent Lawsuit

 Eli Lilly and Company (NYSE: LLY) today announced that the Court of Appeal has ruled that the Alimta® (pemetrexed disodium) vitamin...

Jun 19, 2015, 08:00 ET
Eli Lilly and Company logo.

CYRAMZA® (ramucirumab) Hepatocellular Carcinoma Data Published by The Lancet Oncology

 Eli Lilly and Company (NYSE: LLY) announced that The Lancet Oncology has published results of the Phase III REACH trial that evaluated...